Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Parainfluenza Virus

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

770.0%

Death Rate

Active Ingredients

Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Parainfluenza Virus

Administration Routes

NasalSubcutaneous

Species Affected

Dog 13

Most Affected Breeds

Retriever - Golden 2

Spitz - German Pomeranian 2

Dachshund (unspecified) 1

Terrier (unspecified) 1

Pinscher - Miniature 1

Terrier - Welsh 1

Terrier - Fox Wire 1

Poodle - Toy 1

Dachshund - Miniature 1

Terrier - Bedlington 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 5

Fever 5

Other abnormal test result NOS 5

Skin disorders NOS 3

Anorexia 3

Vomiting 3

Pruritus 2

Skin scab 2

Lack of efficacy - NOS 2

Diarrhoea 2

Injection site lump 2

Urticaria 2

Outcome Breakdown

Ongoing

11 (84.6%)

Recovered/Normal

1 (7.7%)

Died

1 (7.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.